Jump Financial’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-22,568
Closed -$6.21M – 2469
2025
Q4
$6.21M Buy
22,568
+21,499
+2,011% +$5.88M 0.08% 316
2025
Q3
$280K Sell
1,069
-19,170
-95% -$4.66M ﹤0.01% 1523
2025
Q2
$4.43M Buy
+20,239
New +$4.33M 0.05% 449
2024
Q4
– Sell
-1,573
Closed -$472K – 2062
2024
Q3
$472K Buy
+1,573
New +$482K 0.01% 1131
2024
Q2
– Sell
-1,035
Closed -$410K – 2337
2024
Q1
$410K Sell
1,035
-168
-14% -$62.1K 0.01% 1290
2023
Q4
$424K Sell
1,203
-1,863
-61% -$659K 0.01% 1166
2023
Q3
$1.15M Buy
3,066
+1,597
+109% +$618K 0.04% 606
2023
Q2
$562K Buy
+1,469
New +$525K 0.02% 975
2023
Q1
– Sell
-20,452
Closed -$4.81M – 2114
2022
Q4
$4.81M Buy
+20,452
New +$4.85M 0.25% 105
2022
Q2
– Sell
-644
Closed -$264K – 2065
2022
Q1
$264K Sell
644
-2,653
-80% -$1.04M 0.01% 1136
2021
Q4
$1.55M Buy
3,297
+1,797
+120% +$774K 0.1% 266
2021
Q3
$637K Buy
+1,500
New +$632K 0.05% 418
2021
Q2
– Sell
-1,307
Closed -$368K – 1423
2021
Q1
$368K Sell
1,307
-293
-18% -$83.9K 0.03% 524
2020
Q4
$453K Buy
1,600
+83
+5% +$23.3K 0.08% 410
2020
Q3
$417K Buy
+1,517
New +$401K 0.08% 385

Other funds holding WST

Jump Financial's WST Position: Q1 2026 in Review

Jump Financial sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 22,568 shares — an estimated $6.21M sold.

Jump Financial first reported a position in WST in Q3 2020 and held it in 15 quarters. The position peaked at $6.21M in Q4 2025. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Jump Financial reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 22,568 West Pharmaceutical shares in Q1 2026, an estimated $6.21M.
  • Jump Financial first reported a position in West Pharmaceutical in Q3 2020 and held it in 15 quarters.
  • Jump Financial's West Pharmaceutical position peaked at $6.21M in Q4 2025.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.